A Rebound That Still Has Ground to Cover
UnitedHealth's stock has staged a meaningful rebound of roughly 20% through April, yet the share price, recently trading near $321 and down close to 1% on the session, remains nearly 50% below the all-time highs reached at the end of 2024. That recovery looks encouraging on a one-month chart, but in the longer view the company still has considerable distance to reclaim. The market's willingness to participate in any continued recovery will depend less on a simple earnings beat and more on whether the company can prove that its story is credible again.
A Trust and Credibility Problem
The core issue weighing on the name is not purely financial; it is a matter of trust. Allegations of potential fraud in billing practices have raised questions about the durability of forward earnings, and investors are waiting to see whether the company can return to operating cleanly. Forward EPS expectations are improving, though not dramatically rising, and much of the recent upward drift follows a substantial cut in estimates last summer that may ultimately have served as a "kitchen sink" reset.
A change in chief executive leadership about a year ago was intended to stabilize operations and set the business back on an improving trajectory. Over the past year, that improvement has become visible, but a skeptical market is unlikely to fully re-rate the stock until several more quarters of clean execution have passed. The Department of Justice investigations need to clear, billing practices need to be verified as compliant, and the fog of uncertainty needs to lift before sustainable upside is likely to take hold.
What Matters on the Report Card
Given this backdrop, the upcoming quarterly release should not be judged by headline earnings alone. The more important signal will be guidance and the quality of the report. Investors will want to see forward estimates actually begin to rise after the release, paired with a clean update indicating no further regulatory overhang. The narrative, rather than the raw numbers, will drive the next leg of the stock's direction. If management can convincingly communicate that it has cleared the air and is executing consistently, the share price has room to lift; if skepticism lingers, the broader trend of rebuilding trust will likely require at least another quarter or two.
Reading the Options Market
The options market is pricing in a roughly plus-or-minus 6% move around the event, translating to just over $15 in either direction. What stands out more than the expected move itself is the volatility backdrop. The implied volatility percentile sits at only around 17%, meaning the stock's current IV is in the bottom fifth of readings over the past 52 weeks. That is an unusually subdued setup heading into a binary event and suggests that purchasing premium is relatively inexpensive compared to typical earnings conditions.
A Defined-Risk Bullish Call Vertical
With cheap volatility and a story that may take more than one quarter to play out, a pure earnings gamble is less attractive than a directional structure with some duration. A bullish call vertical in the May monthly expiration cycle, with 25 days to go until expiration on May 15, captures that thinking.
The structure involves buying the at-the-money 320 strike call and simultaneously selling the 350 strike call to offset some of the premium outlay. That creates a $30-wide bullish vertical for a debit of roughly $10.70, or about $1,070 per spread. Risk is capped at that debit, while the maximum profit expands to $3,000 if the stock settles above the 350 level at expiration.
The breakeven sits at $330.70, only about 2.5% to 2.7% above the current share price. That target comfortably falls within one standard deviation of the implied move, making the trade's required move modest relative to what the market is already pricing.
Flexibility in Trade Management
A key advantage of this construction is flexibility. With 25 days of duration, there is no obligation to hold through the full three and a half weeks. If the stock rallies toward the 340 to 350 area in the days following the earnings release, all or a portion of the position can be scaled out well before expiration to lock in gains. That ability to parse out the trade mitigates the risk of giving back profits if momentum fades after the initial move.
Bringing the Pieces Together
The setup around this name reflects a broader lesson in trading through uncertainty. When a company faces a credibility repair job that will unfold over multiple quarters, betting exclusively on a single earnings print is rarely the most efficient approach. Instead, pairing a directional bias with a defined-risk structure, while taking advantage of unusually low implied volatility, offers a way to participate in the upside thesis without overpaying for premium. The trade expresses optimism that the company is on an improving path, while respecting the very real risk that trust takes time to rebuild and that a skeptical market may not yet be ready to grant full credit for the turnaround.